Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-VEGF switch vs anti-VEGF + dexamethasone implant for refractory diabetic macular edema
ChiCTR2300073357Phase 4Recruiting
- Sponsor
- Nanning Aier Eye Hospital
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexamethasone in diabetic macular edema (DME) (2 arms), sponsored by Nanning Aier Eye Hospital. Primary endpoints: Best corrected visual acuity and Central macular thickness. Started Jul 2023; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on ChiCTR2300073357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073357.